drugs

An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process.

“My son is smart — he really is — but he was in love.”

Sarepta’s stock sank after studies of Duchenne muscular dystrophy treatments failed their primary endpoints.

The retail pharmacy’s latest convenience play promises speed — but pharmacists warn of safety gaps, limited inventory and confusion for older patients.

“I hardly have any communication with her.”